drugset / Trial / NCT00206778

Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania

NCT00206778

Phase 2 Completed 36 enrolled Beth Israel Medical Center
RandomizedCrossoverSingle-blindTreatment

Summary

We are comparing the efficacy of Lamotrigine to that of Standard of Care Sodium Valproate for the treatment of Mixed Mania. The study hypothesis is that Lamotrigine will be more efficative for treating mixed mania in patients with Bipolar Disorder.

Timeline

Start
2003-07
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule 200 mg Oral
Subject Valproate Small molecule 20 mg/kg Oral